<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940602-2-00108</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Manufacturer of Controlled Substances; Application</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Pursuant to section 1301.43(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on April 15, 1994, Radian Corporation, 8501 Mopac Blvd., P.O. Box 201088, Austin, Texas 78720, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 2,L2,tp0,i1,s25,xs36 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1&blank; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Schedule <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Drug: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=01 g=1 f=1 --> Cathinone (1235)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methcathinone (1237)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Aminorex (1585)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4-Methylaminorex (cis isomer) (1590)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methaqualone (2565)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Ibogaine (7260)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Lysergic acid diethylamide (7315)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Tetrahyrocannabinols (7370)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Mescaline (7381)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3,4-Methylenedioxyamphetamine (7400)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3,4-Methylenedioxy-N-ethylamphetamine (7404)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3,4-Methylenedioxy <!-- PJG 0034 unknown --> meth <!-- PJG 0034 unknown --> amphetamine (7405)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4-Methoxyamphetamine (7411)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Heroin (9200)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Normorphine (9313)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Acetylmethadol (9601)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3-Methylfentanyl (9813)  <!-- PJG 007 0104 intable --> I <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Amphetamine (1100)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methamphetamine (1105)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methylphenidate (1724)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Amobarbital (2125)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Pentobarbital (2270)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Secobarbital (2315)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Phencyclidine (7471)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Oxycodone (9143)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hydromorphone (9150)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Benzoylecgonine (9180)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Hydrocodone (9193)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Meperidine (9230)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methadone (9250)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Morphine (9300)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Oxymorphone (9652)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Alfentanil (9737)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Sufentanil (9740)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Fentanyl (9801)  <!-- PJG 007 0104 intable --> II <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> The firm plans to manufacture deuterated material for use in exempt products. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than July 5, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: May 23, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Gene R. Haislip, <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;13398 Filed 6&hyph;1&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4410&hyph;09&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            